Progress Report on the Palliative Therapy of 100 Patients with Neoplastic Effusions by Intracavitary Low-Dose Interleukin-2

Publisher： Karger

E-ISSN： 1423-0232|60|4|308-312

ISSN： 0030-2414

Source： Oncology, Vol.60, Iss.4, 2001-06, pp. : 308-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of a Standardized Protocol of Intracavitary Recombinant Interferon Alpha-2b in the Palliative Treatment of Malignant Peritoneal Effusions

By  

Oncology, Vol. 61, Iss. 3, 2001-09 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients

By  

Cardiology, Vol. 114, Iss. 1, 2009-04 ,pp. : 32-38

Karger

Access to resources Recommend Favorite

Immunotherapy with histamine dihydrochloride and low‐dose interleukin‐2 favors sustained lymphocyte recovery in acute myeloid leukemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 279-280

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 64-70

Karger

Access to resources Recommend Favorite